Biotech Stocks Continue Momentum in After-Hours Trading Despite Lack of Fresh News

AI Summary1 min read

TL;DR

Several biotech stocks, including Spyre Therapeutics and Solid Biosciences, rose in after-hours trading without new updates, driven by investor sentiment and sector momentum.

Tags

Spyre TherapeuticsSolid BiosciencesAurora CannabisEUDA Healthbiotech stocksafter-hours tradinginvestor sentimentsector momentumstock gains

Several small- and mid-cap biotech stocks, including Spyre Therapeutics, The Oncology Institute, and Solid Biosciences, posted notable gains in after-hours trading despite no new company updates. The movement was driven by investor sentiment and sector momentum, with the biotech sector showing renewed strength. Other stocks, such as Aurora Cannabis and EUDA Health Holdings, also recorded gains without new news. Lexeo Therapeutics and Eledon Pharmaceuticals posted modest gains.

Visit Website